Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: group B FERRIC CARBOXYMALTOSE: FCM will be administered as intravenous infusion of maximum dose of 1000mg diluted in 250 ml of 0.9% NaCl over 15 to 30 minutes. remaining dose will be re
Sponsors
Department of OBGY
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant woman with confirmed moderate iron deficiency anemia (7to 10 gm/dl) Singleton pregnancy Gestational age between 28 to 34 week
Exclusion criteria
Exclusion criteria: Pregnant woman with anemia other than iron deficiency Known case of allergy to iron injection Multiple pregnancy Hypertension Diabetes mellitus Chronic liver disease Renal disorder Cardiovascular disease Thyroid disorder Intestinal resection,bypass Hemosiderosis Hemochromatosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rise in hemoglobin and serum ferritin at 4 week and 8 week from baseline after receiving total dose of iron. Any untoward reaction during transfusion of drug.Timepoint: Rise in hemoglobin and serum ferritin at 4 week and 8 week from baseline after receiving total dose of iron. Any untoward reaction during transfusion of drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum iron studies RBC indices Need for blood transfusion Perinatal outcome Postpartum hemorrhageTimepoint: At 4 week serum iron studies and RBC indices to be studied. At delivery perinatal outcome , postpartum hemorrhage, need for blood transfusion | — |
Countries
India
Contacts
Public ContactDr Charulata Purbia
Dr Rajendra Prasad Govt Medical College Kangra at Tanda
Outcome results
None listed